News about Clean Rooms

Clean Cells opens new facility in Montaigu France

The company plans to recruit 20 new staff members in 2023

Clean Rooms | 06/03/2023 | By Sudeep Soparkar |  918

Puritas Asgard completes API facility cleanroom expansion

The facility will manufacture APIs critical for critical medications and life-saving drugs

Clean Rooms | 28/02/2023 | By Sudeep Soparkar |  827

Charles River Laboratories International expands CDMO facility in Memphis, Tenn

The expanded space is suitable for clinical and commercial cell therapy manufacturing, with an additional nine state-of-the-art processing suites, adding to an existing 16 cleanrooms

Clean Rooms | 14/11/2022 | By Sudeep Soparkar |  833

Medhini Group signs MOUs with multiple India-based cleanroom experts

Medhini is using these two companies to uplift programmes for pharmaceutical manufacturing in Malaysia

Clean Rooms | 04/10/2022 | By Sudeep Soparkar |  728

Cleanroom tech market size to hit $11.46 bn by 2030: Growth Plus Reports

North America dominates the global market with the largest revenue share

Clean Rooms | 18/08/2022 | By Sudeep Soparkar |  991

2nd Annual Next Generation Pharmaceutical Cleanroom Conference will be held in London

The event from October 5 and 6 will focus on cleanroom technology in the pharmaceutical industry

Clean Rooms | 22/07/2022 | By Sudeep Soparkar |  976

Pharma manufacturers to speed up Class A & B medical device registration with CDSCO, demands Maha FDA

The deadline for voluntary registration of Class A and Class B medical devices with the regulator ended on September 30, 2021 and registration became compulsory from October 1, 2021. Manufacturers are required to complete mandatory registration with the CDSCO by September 30, 2022. It has come to the notice that a significant number

Clean Rooms | 16/02/2022 | By Darshana |  685

Novartis inks option, collaboration & licensing pact with BeiGene for TIGIT inhibitor ociperlimab

Novartis announced the signing of an option, collaboration and license agreement with BeiGene, Ltd. for ociperlimab (BGB-A1217), expanding the company?s research and development activities in immuno-oncology. Ociperlimab is a late-stage TIGIT inhibitor, a novel class of anti-cancer therapies that blocks the TIGIT protein receptor

Clean Rooms | 22/12/2021 | By Darshana |  567

VAV Life Sciences invests Rs.15 crore to expand capacity for lipids used in Covid-19 vaccines

Mumbai-based VAV Life Sciences, through its subsidiary VAV Lipids, has announced it has invested Rs.15 crore (US$ 2 million) to boost production capacity to meet the unprecedented overseas demand for lipidic ingredients

Clean Rooms | 24/11/2021 | By Darshana |  902

NPPA extends ceiling price regulation on orthopaedic knee implants for one more year

The National Pharmaceutical Pricing Authority (NPPA) has extended the ceiling price it imposed on orthopaedic knee implants for knee replacement system in August, 2017, to one more year up to September 15, 2022. The ceiling price was applicable till September 15, 2021, according to an earlier notification

Clean Rooms | 20/09/2021 | By Darshana |  685